Gao, H., Ye, G., Lin, Y., Huang, Q., Dong, J., Cao, Y., Zhao, Y., Chen, Q., Ma, S., Ouyang, J., Ye, J., Yang, H., Zhang, Y., Zhang, Y., Zhang, G., Li, W., Zhang, Y., Wu, Z., Lin, Y., Zhu, T., Zhang, L., Yang, C., Yang, M., Peng, H., Chen, B., Chen, Y., Ji, F., Cheng, M., Li, J., Jiang, Z., Wang, K. (2026). Neoadjuvant Taxane Plus Trastuzumab and Pertuzumab With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: The Randomized Noninferiority Phase III neoCARHP Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-02176